Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosa...
Leadership
Michael G. Grey
Executive Chairman
Javier Szwarcberg M.D., M.P.H.
CEO & Director
Samir M. Gharib CPA, M.B.A.
President & CFO
Kirk Ways M.D., Ph.D.
Chief Medical Officer & Director
Bruno Gagnon BPHARM, M.Sc.
Senior Vice President of Clinical Development Operations
